TLDR:
– Kidron Capital Assets announces first close of Women’s Health VC Fund
– Led by female General Partners targeting opportunities in Women’s Health in Europe, the USA, and Israel
In a groundbreaking move, Kidron Capital Assets has successfully closed the first round of funding for a venture capital fund focused on Women’s Health. Led by two female General Partners with extensive experience in the HealthTech sector, the fund aims to capitalize on untapped opportunities in women’s health across Europe, the USA, and Israel.
The fund’s portfolio includes a diverse range of sectors such as medical devices, diagnostics, digital health, therapeutics, and services. This strategic diversity allows Kidron to impact various aspects of women’s health while driving innovation and generating outstanding returns for investors.
Some of the fund’s inaugural investments include companies like Beyond Medicine, Portal, and Renal Guard, each pioneering innovative solutions in the healthcare space. Beyond Medicine focuses on longevity solutions targeting mitochondrial health, while Portal is revolutionizing oncology clinics, and Renal Guard aims to prevent Acute Kidney Injury during cardiac surgeries.
Investors looking to support the future of women’s health and generate high returns can partner with Kidron Capital Assets and make a difference in the industry. For more information, visit their website.
